Cryoglobulinemia

Cryoglobulinemia is a condition where your blood contains too many abnormal proteins called cryoglobulins. When you get cold, these proteins clump together and block tiny blood vessels. This can cause problems like numbness, tingling, and skin issues in your fingers and toes.

Condition

What people with Cryoglobulinemia report

Every report comes from a Lived member, sent anonymously.

Have you tried Rituximab for Cryoglobulinemia?

NameHow it went

About Cryoglobulinemia

What It Is

Cryoglobulinemia is a condition in which the blood carries abnormal antibodies, called cryoglobulins, that thicken and clump together when they cool below body temperature and dissolve again when warmed. Inside the body, these proteins can clog small blood vessels or set off inflammation in their walls. That inflammation is called cryoglobulinemic vasculitis, and it causes most of the symptoms. The most typical signs are small purple or red spots on the lower legs (purpura), tiredness and aching joints. Some people also develop numbness or tingling that starts in the feet, sores on the skin, or kidney inflammation that often shows up first in urine tests. Fingers and toes may turn pale or blue in the cold. Many people whose blood contains cryoglobulins have no symptoms at all, while a small minority develop serious damage to the kidneys, nerves or other organs. Doctors divide cryoglobulinemia into three types according to the antibodies involved. Type I is made of a single, identical antibody produced by an abnormal group of blood cells, and it is usually linked to a blood disorder. Types II and III are called mixed cryoglobulinemia because they contain more than one kind of antibody. The type matters because it points to different causes and different treatments.

Causes & Risk Factors

Cryoglobulinemia is almost always a sign of something else that is pushing the immune system to overproduce antibodies. Finding that underlying cause is a central part of the evaluation. Mixed cryoglobulinemia is most often caused by long-term hepatitis C infection, which accounts for roughly 80 to 90 percent of cases. Hepatitis C can infect immune cells as well as the liver, and years of stimulation can lead some of those cells to produce cryoglobulins. Hepatitis B, HIV and autoimmune diseases such as Sjögren's disease, lupus and rheumatoid arthritis are less common causes. When no cause can be found, doctors call it essential cryoglobulinemia. Type I cryoglobulinemia almost always arises from a disorder of the blood cells that make antibodies. These range from monoclonal gammopathy of undetermined significance (MGUS), a usually slow-growing, precancerous condition, to blood cancers such as Waldenström macroglobulinemia, multiple myeloma, lymphoma and chronic lymphocytic leukemia. Cold does not cause the condition, but it can bring on symptoms in exposed hands and feet, especially in type I. In people already diagnosed, infections such as pneumonia or COVID-19 can set off flares.

How It's Diagnosed

Diagnosis starts with symptoms and an examination, then a blood test for cryoglobulins. The test is more demanding than most: the sample has to be kept at body temperature until the lab separates it, and the serum is then chilled for up to a week to see whether a deposit forms. If the sample cools too early, the result can be falsely negative. Cryoglobulin levels also rise and fall over time, so a negative result does not rule the condition out when symptoms fit, and repeat testing is common. Other blood and urine tests help confirm the picture and look for a cause. In mixed cryoglobulinemia, rheumatoid factor (an antibody that targets other antibodies) is usually high, and C4, part of the immune defense system called complement, is usually low. Protein electrophoresis looks for a single abnormal antibody that can point to a blood cell disorder. Testing for hepatitis C and hepatitis B is standard, and urine and kidney blood tests check whether the kidneys are involved, often before any kidney symptoms appear. When the diagnosis is still uncertain, a small biopsy of affected skin, kidney or nerve can show the inflamed or blocked vessels directly. Nerve conduction tests may be used to measure nerve damage in people with numbness or weakness.

Treatment Options

Treatment depends on the type, the cause and how severe the symptoms are. People with cryoglobulins but no symptoms may need only monitoring. Mild, isolated symptoms such as leg spots may be managed with supportive steps: keeping warm, resting and wearing compression stockings. When hepatitis C is the cause, curing the infection comes first. Direct-acting antivirals are pills that cure hepatitis C in about 90 percent of people. Once the virus is gone, mild to moderate symptoms such as purpura, joint pain and numbness without weakness improve in most people, and skin spots usually respond fastest. The cryoglobulins themselves usually decrease but often do not disappear entirely. For hepatitis B, antivirals control the virus rather than eliminate it, so they are often taken long term. Severe disease, such as kidney inflammation with declining function, dying skin or nerve damage that causes weakness, usually needs treatment aimed at the immune system as well. Rituximab, an antibody medicine given by infusion, removes the B cells (a type of immune cell) that produce cryoglobulins, and it is the main option in these situations. Corticosteroids such as prednisone calm inflammation quickly but cause side effects with long use. For life-threatening complications, doctors may add a stronger immunosuppressant such as cyclophosphamide, along with plasma exchange (plasmapheresis), a procedure that removes the liquid part of the blood carrying the cryoglobulins and replaces it with fluid or donor plasma. Because rituximab can reactivate hepatitis B, people with hepatitis B take antiviral medicine alongside it. Medicines that suppress the immune system also raise the risk of serious infection, which is the central trade-off in deciding how intensively to treat. For mixed cryoglobulinemia without an infection behind it, corticosteroids, sometimes with methotrexate, often control skin and joint symptoms, and rituximab is used when the kidneys or nerves are involved. Type I treatment focuses on the underlying blood disorder, with medicines chosen for that disorder, sometimes combined with plasma exchange and corticosteroids. Evidence for type I comes mainly from small observational studies, and no formal guidelines exist. Nerve pain may also be eased by medicines used for nerve-related pain, such as gabapentin or pregabalin.

What to Expect

The course varies widely. Many people with mixed cryoglobulinemia have mild, long-running symptoms such as recurring leg spots, fatigue and joint aches, while a small number develop serious kidney, nerve or other organ problems. Mixed cryoglobulinemia is rarely fatal, but the outlook is less favorable when the kidneys are affected. In type I, the outlook depends largely on the underlying blood disorder. Curing hepatitis C changes the picture for most people with virus-related disease, but it is not always the end of the story. Symptoms can persist, return or, less often, appear for the first time after the virus is cleared. Relapses are more likely in older people and in those who had severe disease or kidney involvement, and they are often short-lived and respond to treatment. Major infections can set off flares, which is one reason vaccines are recommended: flares after vaccination are less common and milder than those after the infections vaccines prevent. Follow-up usually involves regular review of symptoms, blood and urine tests of kidney function, and repeat cryoglobulin measurements. Mixed cryoglobulinemia also raises the risk of B-cell lymphoma, a cancer of immune cells, which develops in roughly 1 in 10 people with it, so long-term monitoring keeps watch for this. In daily life, dressing warmly, avoiding prolonged cold and limiting long periods of standing when leg spots tend to appear may reduce symptoms.

When to Seek Help

See a doctor if you notice recurring purple spots on your lower legs, ongoing joint pain and fatigue, or numbness in your feet, especially if you have hepatitis C or a blood disorder. If you already have cryoglobulinemia, tell your care team about new or gradually worsening symptoms. Contact your care team promptly, the same day if possible, for new skin ulcers, numbness or weakness that is spreading quickly, or signs that the kidneys may be affected, such as dark or foamy urine, passing much less urine or new swelling in the legs. Seek emergency care for a finger or toe that turns dark or black, sudden changes in vision, new confusion or sudden weakness, coughing up blood or severe breathlessness, or severe abdominal pain or bloody stool. These can signal blocked blood flow, overly thick blood or inflamed vessels in vital organs, which need urgent treatment.

Questions to Ask Your Doctor

  1. 1.What type of cryoglobulinemia do I have, and what is causing it?
  2. 2.Are my kidneys or nerves affected, and how will we check them over time?
  3. 3.If my hepatitis C is cured, how likely is it that my symptoms will go away, and what happens if they don't?
  4. 4.What are the benefits and risks of rituximab or other immune-suppressing treatment in my situation?
  5. 5.Which signs of a flare or complication should prompt me to call you?

Last reviewed • Oct 2026

Educational content, not medical advice.